Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies
Dry eye disease is a common disease of the tear film caused by decreased tear production or increased evaporation. The objective of this study was to develop and evaluate poly (dl-lactide-co-glycolide) (PLGA) nanoparticles for CsA (CsA) ophthalmic delivery, for the treatment of dry eye disease. Topi...
Saved in:
| Main Authors: | Vijay D. Wagh, Dipak U. Apar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Nanotechnology |
| Online Access: | http://dx.doi.org/10.1155/2014/683153 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclosporine (0.05%) Combined with Diclofenac Sodium Eye Drops for the Treatment of Dry Eye Disease
by: Run Bai, et al.
Published: (2022-01-01) -
Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery
by: Gui-Feng Tong, et al.
Published: (2017-09-01) -
Bioactive PLGA polymer nanoparticle loaded gels for atopic dermatitis treatment
by: Eun Ju Park, et al.
Published: (2025-04-01) -
Comparison of effects of cyclosporine 0.05% and 0.1% in dry eye with Sjögren’s syndrome
by: Donghyun Jee, et al.
Published: (2025-07-01) -
The efficacy and safety of nanoemulsion compared to conventional cyclosporine in dry eye disease: A systematic review and meta-analysis
by: Afaf Bachira Gouhiri, et al.
Published: (2025-10-01)